Atezolizumab + Bevacizumab Shows Benefit in Met Renal CA
Progression - free survival benefit for patients with untreated metastatic renal cell carcinoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Conference News, Source Type: news
More News: Avastin | Cancer & Oncology | Carcinoma | Conferences | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology